Annals of Oncology

introduction:

ESMO Education
Ann Oncol 17: x3. [PDF] [Request Permissions]

ESMO-MORA
Ann Oncol 17: x6-x7. [PDF] [Request Permissions]

ESMO Fellowship Program
Ann Oncol 17: x8-x9. [PDF] [Request Permissions]

Visits to Translational Research Units (TRU) for Fellows
Ann Oncol 17: x10. [PDF] [Request Permissions]

Young Oncologists
Ann Oncol 17: x11. [PDF] [Request Permissions]

Board of Officers
Ann Oncol 17: x12. [PDF] [Request Permissions]

Introduction
Ann Oncol 17: x14. [PDF] [Request Permissions]

educational sessions:

J. Wagstaff

New horizons in the treatment of renal cell cancer
Ann Oncol 17: x19-x22; doi:10.1093/annonc/mdl230 [PDF] [Request Permissions]

C. N. Sternberg

Muscle invasive and metastatic bladder cancer
Ann Oncol 17: x23-x30; doi:10.1093/annonc/mdl231 [PDF] [Request Permissions]

C. Kollmannsberger, F. Honecker, and C. Bokemeyer

Treatment of germ cell tumors – update 2006
Ann Oncol 17: x31-x35; doi:10.1093/annonc/mdl232 [PDF] [Request Permissions]

J. Bourhis, J. Guigay, S. Temam, and J. P. Pignon

Chemo-radiotherapy in head and neck cancer
Ann Oncol 17: x39-x41; doi:10.1093/annonc/mdl233 [PDF] [Request Permissions]

R. Hitt

Induction chemotherapy in head and neck cancer
Ann Oncol 17: x42-x44; doi:10.1093/annonc/mdl234 [PDF] [Request Permissions]

L. Licitra, L. Locati, and P. Bossi

Biological agents in head and neck cancer
Ann Oncol 17: x45-x48; doi:10.1093/annonc/mdl235 [PDF] [Request Permissions]

M. Castiglione-Gertsch

Adjuvant treatment of breast cancer: sequence and duration of hormonal therapy
Ann Oncol 17: x51-x53; doi:10.1093/annonc/mdl236 [PDF] [Request Permissions]

G. Mariani and L. Gianni

Adjuvant trastuzumab in early breast cancer
Ann Oncol 17: x54-x58; doi:10.1093/annonc/mdl237 [PDF] [Request Permissions]

M. Clarke

Meta-analyses of adjuvant therapies for women with early breast cancer: the Early Breast Cancer Trialists' Collaborative Group overview
Ann Oncol 17: x59-x62; doi:10.1093/annonc/mdl238 [PDF] [Request Permissions]

A. Bikfalvi

Angiogenesis: health and disease
Ann Oncol 17: x65-x70; doi:10.1093/annonc/mdl239 [PDF] [Request Permissions]

B. Besse, J.-P. Armand, and J.-C. Soria

Targeting angiogenesis with oral agents
Ann Oncol 17: x71-x75; doi:10.1093/annonc/mdl240 [PDF] [Request Permissions]

R. Bicknell

Targeting angiogenesis with monoclonal antibodies
Ann Oncol 17: x76-x78; doi:10.1093/annonc/mdl241 [PDF] [Request Permissions]

O. Dotsenko and A. K. Kakkar

Thrombosis and cancer
Ann Oncol 17: x81-x84; doi:10.1093/annonc/mdl242 [PDF] [Request Permissions]

H. C. Schouten

Neutropenia management
Ann Oncol 17: x85-x89; doi:10.1093/annonc/mdl243 [PDF] [Request Permissions]

F. Roila, S. Fatigoni, and G. Ciccarese

Daily challenges in oncology practice. What do we need to know about antiemetics?
Ann Oncol 17: x90-x94; doi:10.1093/annonc/mdl244 [PDF] [Request Permissions]

R. A. Stahel

Non-small cell lung cancer: second-line and beyond
Ann Oncol 17: x97-x100; doi:10.1093/annonc/mdl245 [PDF] [Request Permissions]

Y. Loriot, J.-C. Soria, and T. Le Chevalier

Expanding role of chemotherapy in lung cancer
Ann Oncol 17: x101-x107; doi:10.1093/annonc/mdl246 [PDF] [Request Permissions]

E. Felip and E. Vilar

The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy
Ann Oncol 17: x108-x112; doi:10.1093/annonc/mdl247 [PDF] [Request Permissions]

N. Starling and D. Cunningham

The role of systemic therapy for localised gastric cancer
Ann Oncol 17: x115-x121; doi:10.1093/annonc/mdl248 [PDF] [Request Permissions]

D. Arnold, R. Siewczynski, and H.-J. Schmoll

The integration of targeted agents into systemic therapy of metastatic colorectal cancer
Ann Oncol 17: x122-x128; doi:10.1093/annonc/mdl249 [PDF] [Request Permissions]

A. Cervantes, I. Chirivella, E. Rodriguez-Braun, S. Campos, S. Navarro, and E. García Granero

A multimodality approach to localized rectal cancer
Ann Oncol 17: x129-x134; doi:10.1093/annonc/mdl250 [PDF] [Request Permissions]

M. A. Dimopoulos, E. Kastritis, and A. Anagnostopoulos

Hematological malignancies: myeloma
Ann Oncol 17: x137-x143; doi:10.1093/annonc/mdl251 [PDF] [Request Permissions]

M. Palma, P. Kokhaei, J. Lundin, A. Choudhury, H. Mellstedt, and A. Österborg

The biology and treatment of chronic lymphocytic leukemia
Ann Oncol 17: x144-x154; doi:10.1093/annonc/mdl252 [PDF] [Request Permissions]

W. Hiddemann and M. Unterhalt

Current treatment strategies in follicular lymphomas
Ann Oncol 17: x155-x159; doi:10.1093/annonc/mdl253 [PDF] [Request Permissions]

G. Viale and M. G. Mastropasqua

Diagnostic and therapeutic management of carcinoma of unknown primary: histopathological and molecular diagnosis
Ann Oncol 17: x163-x167; doi:10.1093/annonc/mdl254 [PDF] [Request Permissions]

G. Jerusalem, A. Rorive, G. Ancion, R. Hustinx, and G. Fillet

Diagnostic and therapeutic management of carcinoma of unknown primary: radio-imaging investigations
Ann Oncol 17: x168-x176; doi:10.1093/annonc/mdl255 [PDF] [Request Permissions]

K. Fizazi

Treatment of patients with specific subsets of carcinoma of an unknown primary site
Ann Oncol 17: x177-x180; doi:10.1093/annonc/mdl256 [PDF] [Request Permissions]

M. Brada

Radiotherapy in malignant glioma
Ann Oncol 17: x183-x185; doi:10.1093/annonc/mdl257 [PDF] [Request Permissions]

M. J. van den Bent

Adjuvant treatment of high grade gliomas
Ann Oncol 17: x186-x190; doi:10.1093/annonc/mdl258 [PDF] [Request Permissions]

M. E. Hegi, A. Murat, W. L. Lambiv, and R. Stupp

Brain tumors: molecular biology and targeted therapies
Ann Oncol 17: x191-x197; doi:10.1093/annonc/mdl259 [PDF] [Request Permissions]

F. H. Schröder

Biomarkers and screening for prostate cancer
Ann Oncol 17: x201-x206; doi:10.1093/annonc/mdl260 [PDF] [Request Permissions]

R. Postma

Treatment of prostate cancer
Ann Oncol 17: x207-x210; doi:10.1093/annonc/mdl261 [PDF] [Request Permissions]

A. Horwich

Systemic treatment for prostate cancer
Ann Oncol 17: x211-x213; doi:10.1093/annonc/mdl262 [PDF] [Request Permissions]

W. A. A. Tjalma

Cervical cancer and prevention by vaccination: results from recent trials
Ann Oncol 17: x217-x223; doi:10.1093/annonc/mdl263 [PDF] [Request Permissions]

P. G. Rose

Concurrent chemoradiation for locally advanced carcinoma of the cervix: where are we in 2006?
Ann Oncol 17: x224-x229; doi:10.1093/annonc/mdl264 [PDF] [Request Permissions]

J. A. Green and G. Lainakis

Cytotoxic chemotherapy for advanced or recurrent cervical cancer
Ann Oncol 17: x230-x232; doi:10.1093/annonc/mdl265 [PDF] [Request Permissions]

A. du Bois and P. Harter

The role of surgery in advanced and recurrent ovarian cancer
Ann Oncol 17: x235-x240; doi:10.1093/annonc/mdl266 [PDF] [Request Permissions]

J. B. Vermorken

Intraperitoneal chemotherapy in advanced ovarian cancer: recognition at last
Ann Oncol 17: x241-x246; doi:10.1093/annonc/mdl267 [PDF] [Request Permissions]

E. A. Eisenhauer

New targets and non-cytotoxics in ovarian cancer
Ann Oncol 17: x247-x250; doi:10.1093/annonc/mdl268 [PDF] [Request Permissions]

M. P. A. Ebert, J. Yu, F. Lordick, and C. Röcken

Proteomics in gastrointestinal cancer
Ann Oncol 17: x253-x258; doi:10.1093/annonc/mdl269 [PDF] [Request Permissions]

C. Sotiriou and C. Desmedt

Gene expression profiling in breast cancer
Ann Oncol 17: x259-x262; doi:10.1093/annonc/mdl270 [PDF] [Request Permissions]

J. Stoehlmacher

The impact of genomics and proteomics in the clinic: functional genetic polymorphisms and their value in response and toxicity prediction in solid tumours
Ann Oncol 17: x263-x268; doi:10.1093/annonc/mdl271 [PDF] [Request Permissions]

challenge your expert sessions:

A. Costa

Precancerous lesions of the breast
Ann Oncol 17: x271-x273; doi:10.1093/annonc/mdl272 [PDF] [Request Permissions]

A. Hochhaus

Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors
Ann Oncol 17: x274-x279; doi:10.1093/annonc/mdl273 [PDF] [Request Permissions]

H. Joensuu

Gastrointestinal stromal tumor (GIST)
Ann Oncol 17: x280-x286; doi:10.1093/annonc/mdl274 [Abstract] [PDF] [Request Permissions]

D. C. Sullivan

Molecular imaging in oncology
Ann Oncol 17: x287-x292; doi:10.1093/annonc/mdl275 [PDF] [Request Permissions]

S. D. Fosså, T. B. Johannesen, and G. Lehne

Long-term outcome after adult-onset cancer
Ann Oncol 17: x293-x298; doi:10.1093/annonc/mdl276 [PDF] [Request Permissions]

F. Strasser

Palliative care: evaluation instruments in daily clinical practice
Ann Oncol 17: x299-x303; doi:10.1093/annonc/mdl277 [PDF] [Request Permissions]

J. Guigay, S. Temam, J. Bourhis, J.-P. Pignon, and J.-P. Armand

Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy
Ann Oncol 17: x304-x307; doi:10.1093/annonc/mdl278 [PDF] [Request Permissions]

J. Taieb, J. C. Barbare, and P. Rougier

Medical treatments for hepatocellular carcinoma (HCC): what's next?
Ann Oncol 17: x308-x314; doi:10.1093/annonc/mdl279 [PDF] [Request Permissions]

T. R. Wilson, D. B. Longley, and P. G. Johnston

Chemoresistance in solid tumours
Ann Oncol 17: x315-x324; doi:10.1093/annonc/mdl280 [PDF] [Request Permissions]

M. O. Leach

MRI for breast cancer screening
Ann Oncol 17: x325-x331; doi:10.1093/annonc/mdl281 [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.